DHAKA, Feb 13, 2017 (BSS)- The New York Times, one of the world's most influential newspapers, featured icddr,b's decades-long legacy in battling cholera and the history of innovating treatment that saved millions of lives till this day.
The article, originally published on February 6, was reprinted as the front page cover story of its February 11-12 International Edition.
Commenting on the unprecedented coverage, icddr,b's Acting Chief Operating Officer and Principal Communications Lead, Catherine Spencer, said this would further fuel our passion towards creating a world in which more people survive and enjoy healthy lives.
"We are thrilled and honoured to have been covered by a news organisation having over 160 years of rich history in journalism," Spencer said.
Established in 1960, icddr,b is an international public health research institution based in Dhaka, Bangladesh. It has been at the forefront of discovering low cost solutions to key health challenges facing people living in poverty and provides robust evidence of their effectiveness at a large scale.
Dedicated to saving lives through research and treatment, icddr,b addresses some of the most critical health concerns facing the world today.
In the article titled "Turning the Tide against Cholera", the New York Times said after 35 years of work, researchers in Bangladesh and elsewhere have developed an effective cholera vaccine, which has been accepted by the World Health Organization.
Referring to treatment protocol, it said the treatment is so effective that it saves 99.9 percent of all victims was pioneered here. The World Health Organization estimates that it has saved about 50 million lives in the past four decades.
In the article, the New York Times also despaired elaborately the history of the cholera and the development of its treatment in the icddr,b.
Source: Bangladesh Sangbad Sangstha (BSS)